📰 Evaluate Efficacy News
Page 6 - Evaluate Efficacy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evaluate Efficacy. Real-time updates on events, politics, business and more.
January 25, 2022
If you test positive for COVID, you could help other patients in the future by participating in a study. Essentia Health is part of this effort.
January 25, 2022
If you test positive for COVID, you could help other patients in the future by participating in a study. Essentia Health is part of this effort.
January 23, 2022
Lakeland Regional Health is participating in an national study to test the effectiveness of ivermectin against COVID-19.
January 14, 2022
NORTH CHICAGO, Ill., Jan. 14, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RI...
January 14, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of...
January 14, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib) for the treatment of...
January 7, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted applications seeking approvals for upadacitinib (RINVOQ®, 15 mg once daily) to the...
January 7, 2022
NORTH CHICAGO, Ill., Jan. 7, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted applications seeking approvals for upadacitinib (RINVOQ®, 15 mg once daily) to the U.S.
December 23, 2021
/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with SK...
December 23, 2021
DUBLIN, Dec. 23, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with SK Biopharmaceuticals